Back

Proteomic Analysis of Human Chronic Traumatic Encephalopathy Brain Implicates Proteasome and Ribosome Dysfunction in Disease Progression

Pennington, H. E.; Shapiro, D.; Empawi, J.; Aytan, N.; Alvarez, V.; Mez, J.; Alosco, M. L.; Zhang, X.; McKee, A. C.; Stein, T. D.; Cherry, J. D.; Labadorf, A.

2026-02-14 molecular biology
10.64898/2026.02.13.705123 bioRxiv
Show abstract

Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease associated with repeated head injuries (RHI) commonly experienced by contact sport athletes, military personnel, and domestic abuse victims. Despite growing recognition of CTE, the molecular mechanisms underlying disease progression remain poorly understood. This study aims to identify proteomic alterations associated with CTE pathology and clinical features to elucidate key biological pathways involved in disease pathogenesis. SomaScan 7k high-throughput proteomics was performed on 204 dorsolateral prefrontal cortex samples from the Boston University CTE Center Brain Bank. We identified differentially expressed proteins associated with CTE, hyperphosphorylated tau (ptau) pathology, duration of contact sports play, dementia status, and Cognitive Difficulty Scale (CDS) scores. Gene set enrichment analysis revealed that proteasome subunit proteins and related pathways were strongly associated with CTE progression and correlated with years of contact sports play. Reduction in ribosomal proteins and pathways was closely associated with ptau burden. Additionally, multiple models demonstrated significant alterations in MAPK-related cell signaling pathways. These findings advance our understanding of CTE progression and identify mechanisms correlated with key pathological features of the disease. Validation of these results could inform the development of diagnostics and treatments for CTE.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.1%
17.8%
2
PLOS ONE
4510 papers in training set
Top 21%
8.6%
3
Frontiers in Aging Neuroscience
67 papers in training set
Top 0.4%
6.9%
4
Annals of Neurology
57 papers in training set
Top 0.3%
4.9%
5
International Journal of Molecular Sciences
453 papers in training set
Top 2%
4.0%
6
Scientific Reports
3102 papers in training set
Top 35%
3.7%
7
Cell Death Discovery
51 papers in training set
Top 0.2%
3.3%
8
Journal of Advanced Research
15 papers in training set
Top 0.1%
2.4%
50% of probability mass above
9
Journal of Proteome Research
215 papers in training set
Top 1%
2.1%
10
Frontiers in Molecular Biosciences
100 papers in training set
Top 1%
1.9%
11
Molecular Neurodegeneration
49 papers in training set
Top 0.4%
1.7%
12
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 5%
1.5%
13
Neurotherapeutics
11 papers in training set
Top 0.2%
1.5%
14
Journal of the American Society for Mass Spectrometry
33 papers in training set
Top 0.3%
1.2%
15
Cells
232 papers in training set
Top 4%
1.1%
16
Biomolecules
95 papers in training set
Top 1%
1.0%
17
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.0%
18
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.8%
19
Science Advances
1098 papers in training set
Top 29%
0.8%
20
Molecular Neurobiology
50 papers in training set
Top 1.0%
0.8%
21
Journal of Neuroinflammation
50 papers in training set
Top 0.9%
0.8%
22
ACS Chemical Neuroscience
60 papers in training set
Top 2%
0.8%
23
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.7%
24
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 6%
0.7%
25
Acta Neuropathologica
51 papers in training set
Top 1%
0.7%
26
Translational Psychiatry
219 papers in training set
Top 4%
0.7%
27
Frontiers in Molecular Neuroscience
43 papers in training set
Top 1%
0.7%
28
Nature Communications
4913 papers in training set
Top 65%
0.7%
29
Frontiers in Neurology
91 papers in training set
Top 6%
0.7%
30
Human Genetics and Genomics Advances
70 papers in training set
Top 1.0%
0.7%